Jan Degenhardt

Angestellt, Digital Health Center of Excellence - Product Manager, Carl Zeiss Meditec AG

Munich, Deutschland

Über mich

Experienced Product Manager driving digital transformation in MedTech. Currently responsible for the global product strategy and development of digital research applications at Carl Zeiss Meditec AG. Proven success in coordinating strategy execution, pricing projects, and data analytics. Previous roles include supporting M&A due diligence, leading industry studies, and implementing strategic priorities. Academic background in Business Chemistry with expertise in technology management and analytical chemistry. Let's connect to discuss how my experience can contribute to your organization's success in the ever-evolving MedTech landscape.

Fähigkeiten und Kenntnisse

Mass spectrometry
Microsoft Excel
PowerPoint
Project Management
LaTeX Editor
Proteomics
Spectroscopy
Business Development
Corporate Development Management

Werdegang

Berufserfahrung von Jan Degenhardt

  • Bis heute 1 Jahr und 4 Monate, seit Feb. 2023

    Digital Health Center of Excellence - Product Manager

    Carl Zeiss Meditec AG

    • Define & execute global product strategy for digital research applications within Carl ZEISS Meditec • Coordinate product development and go-to-market for research apps and platform

  • 1 Jahr und 5 Monate, Okt. 2021 - Feb. 2023

    Strategic Corporate Development - Manager

    ZEISS

    • Coordinate strategy execution of MedTech unit in a key country for ZEISS including the definition and piloting of engine for business innovation projects • Lead data analytics workstream as part of larger operational excellence project to facilitate company transformation • Lead pricing and monetization pilot for innovative MedTech device including the definition of company-wide project blueprint

  • 1 Jahr und 1 Monat, Okt. 2020 - Okt. 2021

    Strategic Corporate Development - Junior Manager

    ZEISS

    • Lead commercial due diligence workstream for M&A projects with deal volume up to €50mn+ • Run 5+ industry studies supporting market entry decisions • Lead rollout of OKR (Objectives & Key Results) within company (30k+ employees)

  • 10 Monate, Aug. 2019 - Mai 2020

    Mass Spectrometry and Proteomics Group - Visiting Researcher

    University of South Australia

    • Development of mass spectrometry-based assay addressing issue having annual €100k+ profit impact for brewing industry client •Development of protein quantification assay significantly outperforming industry status-quo • Optimization of analytical sample preparation methods for proteomics workflow

  • 4 Monate, Mai 2018 - Aug. 2018

    Strategic Corporate Development - Intern

    ZEISS

    • Support business development initiatives with market & technology research of medical technology and pharmacy markets • Definition of a strategic vision on trends in robotics • Support implementation of best-practice service platform

  • 3 Monate, Aug. 2017 - Okt. 2017

    NMR Center - Research Intern

    National Institute of Chemistry

    • Characterization of DNA structure with 2D-NMR • Syntheses of DNA to enable research on cancer prevention • Analysis of human gut microbiota to identify drug-related changes

Ausbildung von Jan Degenhardt

  • 2 Jahre und 7 Monate, Apr. 2018 - Okt. 2020

    Business Chemistry

    Christian-Albrechts-Universität zu Kiel

    Major: Technology management/SCM and Analytical chemistry Master Thesis: Quantification of Proteinase A in beer using mass spectrometry methods

  • 3 Jahre und 6 Monate, Okt. 2014 - März 2018

    Business Chemistry

    Christian-Albrechts-Universität zu Kiel

    Major: Physical Chemistry Bachelor-Thesis: Femtosecond time-resolved fluorescence upconversion spectroscopy of potential ESIPT switches

Sprachen

  • Deutsch

    Muttersprache

  • Englisch

    Fließend

  • Spanisch

    Grundlagen

21 Mio. XING Mitglieder, von A bis Z